Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.10p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.50
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 384,180
  • Market Cap: £346.50m
  • RiskGrade: 119
  • Beta: 0.00

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Andrew Franklin 248,503 £159,290
Richard Jones 68,000 £43,588

Major Shareholders

Notifier** Holding Value*
DBAY Advisors Limited 151,076,240 £96,839,870
Slater Investments Ltd 70,675,966 £45,303,294
Kempen Capital Management N.V. 55,157,348 £35,355,860
Sand Grove Capital Management LLP 53,933,863 £34,571,606
MVM Life Science Partners 40,561,900 £26,000,178
Blackrock, Inc. 32,282,356 £20,692,990
Rathbone Investment Mgt 25,968,567 £16,645,851
GVQ Investment Management Ltd 23,691,460 £15,186,226
Polar Capital 23,252,692 £14,904,976
Royal Bank of Canada 20,645,236 £13,233,596
Investec Asset Management 19,844,776 £12,720,501
Aviva plc & its subsidiaries 18,255,256 £11,701,619
Lombard Odier Asset Management (Europe) Limited 16,761,194 £10,743,925
Artemis Investment Management LLP 16,304,802 £10,451,378
John Dawson 16,200,462 £10,384,496
Stella Anne Dawson 15,576,323 £9,984,423
Old Mutual Asset Managers (UK) Ltd 7,488,920 £4,800,398

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.10p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.50
52 Week Low 29.35
Volume 384,180
Shares Issued 540.57m
Market Cap £346.50m
Beta 0.00
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.41% below the market average68.41% below the market average68.41% below the market average68.41% below the market average68.41% below the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average
Price Trend
72.97% above the market average72.97% above the market average72.97% above the market average72.97% above the market average72.97% above the market average
83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average83.67% above the sector average
Income Not Available
Growth
28.76% below the market average28.76% below the market average28.76% below the market average28.76% below the market average28.76% below the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 01-Apr-2025

Time Volume / Share Price
16:35 210,216 @ 64.10p
16:35 914 @ 64.10p
16:35 1,345 @ 64.10p
16:35 1 @ 64.10p
16:35 1 @ 64.10p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page